Concerning MYD88, we only detected the classical pathogenic hotspot L265P mutation, which was validated by Sanger sequencing in all PCNSL samples investigated (100%, n = 26, Supplementary Data 4 and 5). The gene discussed is MYD88; the disease is primary central nervous system lymphoma.